SCHEMBL17477141

SCHEMBL17477141

CN1CCC(c2cccnc2N)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 2/20 0.43
HTR1B P28222 2/20 0.43
HTR1F P30939 1/20 0.43
HTR2A P28223 2/20 0.43
HTR2B P41595 2/20 0.43
HTR6 P50406 2/20 0.43
SSTR4 P31391 2/20 0.42
SSTR1 P30872 1/20 0.42
CYP1A2 P05177 1/20 0.42
CHRM2 P08172 1/20 0.42
HTR1A P08908 1/20 0.42
ADRA2A P08913 1/20 0.42
CYP2D6 P10635 1/20 0.42
CHRM1 P11229 1/20 0.42
CYP2C9 P11712 1/20 0.42
TSHR P16473 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
DRD1 P21728 1/20 0.42
HTR2C P28335 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30469945 0.84 PDK2 (0.46) CYP1A2HTR1AADRA2ACYP2D6TSHR
SCHEMBL934667 0.84 PDK2 (0.46) CYP1A2HTR1AADRA2ACYP2D6TSHR
SCHEMBL31316641 0.83 HRH3 (0.38) CHRM2CYP2D6CHRM1NOS3NOS1
Potassium SCHEMBL29930626 0.82 PDK2 (0.45) CYP1A2HTR1AADRA2ACYP2D6TSHR
SCHEMBL26971374 0.81 HTR6 (0.46) HTR2AHTR2BHTR6SSTR4SSTR1
SCHEMBL29353268 0.81 HTR6 (0.46) HTR2AHTR2BHTR6SSTR4SSTR1
SCHEMBL5954915 0.80 NOS1 (0.42) HTR1ANOS3NOS1NOS2
SCHEMBL28763152 0.80 NOS3 (0.42) HTR1ANOS3NOS1NOS2
SCHEMBL2718434 0.79 CYP11B2 (0.43) HTR1AGAASMN1; SMN2NOS3NOS1
SCHEMBL4583160 0.78 HTR2A (0.41) HTR1FHTR2AHTR2BHTR6SSTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119421884-A Polymorphic compounds and uses thereof 普莱鲁德疗法有限公司 2025-02-11 CN disclosed
CN-116940563-A CDK inhibitors and their use as pharmaceuticals 普莱鲁德疗法有限公司 2023-10-24 CN disclosed
WO-2023178547-A1 POLYMORPHIC COMPOUNDS AND USES THEREOF PRELUDE THERAPEUTICS, INCORPORATED (US) 2023-09-28 WO disclosed
CN-116583283-A CDK inhibitors and their use as pharmaceuticals 普莱鲁德疗法有限公司 2023-08-11 CN disclosed
WO-2016015605-A1 COMPOUNDS AS CDK SMALL-MOLECULE INHIBITORS AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2016-02-04 WO disclosed